Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham S Taylor

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|October 18, 2019
The T-cell Response to Epstein-Barr Virus-New Tricks From an Old DogHeather M Long, Benjamin J Meckiff, Graham S Taylor
British Journal of Cancer|October 1, 2022
Role of AI and digital pathology for colorectal immuno-oncologyMohsin Bilal, Mohammed Nimir, David Snead, et al.
Annual Review of Immunology|March 24, 2007
Cellular responses to viral infection in humans: lessons from Epstein-Barr virusAndrew D Hislop, Graham S Taylor, Delphine Sauce, et al.
BMC Infectious Diseases|February 4, 2023
Mendelian randomisation identifies priority groups for prophylactic EBV vaccinationMarisa D Muckian, James F Wilson, Graham S Taylor, et al.
Reviews in Medical Virology|April 25, 2026
Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and CancersMarisa D Muckian, Graham S Taylor, John Diaz-Decaro, et al.
Annual Review of Immunology|February 24, 2015
The immunology of Epstein-Barr virus-induced diseaseGraham S Taylor, Heather M Long, Jill M Brooks, et al.
Scientific Reports|June 28, 2019
Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategyLara Goscé, Joanne R Winter, Graham S Taylor, et al.
Journal of Virology|April 14, 2005
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivityNancy H Gudgeon, Graham S Taylor, Heather M Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope displayCarol S Leung, Tracey A Haigh, Laura K Mackay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cellsGraham S Taylor, Heather M Long, Tracey A Haigh, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|October 18, 2019
The T-cell Response to Epstein-Barr Virus-New Tricks From an Old DogHeather M Long, Benjamin J Meckiff, Graham S Taylor
British Journal of Cancer|October 1, 2022
Role of AI and digital pathology for colorectal immuno-oncologyMohsin Bilal, Mohammed Nimir, David Snead, et al.
Annual Review of Immunology|March 24, 2007
Cellular responses to viral infection in humans: lessons from Epstein-Barr virusAndrew D Hislop, Graham S Taylor, Delphine Sauce, et al.
BMC Infectious Diseases|February 4, 2023
Mendelian randomisation identifies priority groups for prophylactic EBV vaccinationMarisa D Muckian, James F Wilson, Graham S Taylor, et al.
Reviews in Medical Virology|April 25, 2026
Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and CancersMarisa D Muckian, Graham S Taylor, John Diaz-Decaro, et al.
Annual Review of Immunology|February 24, 2015
The immunology of Epstein-Barr virus-induced diseaseGraham S Taylor, Heather M Long, Jill M Brooks, et al.
Scientific Reports|June 28, 2019
Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategyLara Goscé, Joanne R Winter, Graham S Taylor, et al.
Journal of Virology|April 14, 2005
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivityNancy H Gudgeon, Graham S Taylor, Heather M Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope displayCarol S Leung, Tracey A Haigh, Laura K Mackay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cellsGraham S Taylor, Heather M Long, Tracey A Haigh, et al.
Pageof 6